NASDAQ Biotechnology Index ETF Overview

With 5 ETFs traded in the U.S. markets, NASDAQ Biotechnology Index ETFs gather total assets under management of $7.19B. The average expense ratio is 0.85%. NASDAQ Biotechnology Index ETFs can be found in the following asset classes:

  • Equity

The largest NASDAQ Biotechnology Index ETF is the iShares NASDAQ Biotechnology ETF IBB with $7.19B in assets. In the last trailing year, the best performing NASDAQ Biotechnology Index ETF was the BIS at 8.84%. The most-recent ETF launched in the NASDAQ Biotechnology Index space was the ProShares UltraPro Nasdaq Biotechnology UBIO in 06/23/15.

ETF Report

Sectors In Review: September 2019

Sector ETFs recorded largely positive performance during July.

ETF Report

Sectors In Review: June 2019

Health care and real estate struggled during the month.

ETF Report

Sectors In Review: April 2019

Sector ETFs had a mostly positive February.

Features and News

CNBC ETF Edge: Biotech Getting Sick?

How you should trade biotech ETFs.

ETF Report

 Sectors In Review: January 2019

November was mostly positive for sector ETFs.

ETF Report

 Sectors In Review: December 2018

Sector ETFs got clobbered in October.

ETF Report

 Sectors In Review: July 2018

Sectors shined in May, with several seeing all their ETFs land in positive territory.

ETF Report

 October 2017 Sectors In Review

October was a mixed month for sectors.

ETF Report

 Sectors In Review

August was a grim month for four sectors, but fairly decent for the rest.